Jul 2
|
Hemostemix's VesCell Sales are Legal in Florida as it Pivots to Allow Non-FDA Approved Stem Cell Treatments!
|
Jun 27
|
Croom Lawrence Joins Hemostemix with Revenue Share Agreement and VesCell.Health Launch
|
Jun 26
|
Hemostemix Announces Lead Order of $1,500,000 and the Full Repayment of $2,500,000 Convertible Debenture
|
Apr 23
|
Hemostemix Engages PatentVest to Strengthen its Global Patent Portfolio
|
Feb 14
|
Hemostemix Provides Corporate Update
|
Feb 11
|
Hemostemix PR Inc. Congratulates Luis Munoz Marin International Airport on Achieving CEIV Pharma Certification
|
Feb 10
|
Hemostemix Contracts ProConsul to Ramp up Engagement with New Investors
|
Jan 27
|
Hemostemix Up-lists to TradeGateExchange in Germany
|
Jan 23
|
Hemostemix Up-Lists to OTCQB While it Presents its Global Scale-Up Strategy at Two Investor Conferences in Puerto Rico
|
Jan 22
|
Hemostemix Announces Grant of Stock Options
|
Jan 2
|
Hemostemix is Up-Listing in the USA to Generate Liquidity
|
Dec 31
|
Hemostemix's Social Media Awareness of "Your Fountain of Youth"(TM) Regenerative Medicine Treatments Is Gaining Traction
|